Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$499M |
| 2 |
Booking.com
BKNG
|
+$328M |
| 3 |
3M
MMM
|
+$285M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$283M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$275M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$552M |
| 2 |
iShares US Healthcare ETF
IYH
|
+$393M |
| 3 |
TJX Companies
TJX
|
+$389M |
| 4 |
iShares US Industrials ETF
IYJ
|
+$387M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$384M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.14% |
| 2 | Financials | 13.78% |
| 3 | Healthcare | 13.65% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Marcus Corp
MCS
$929M
| $1.58M | ﹤0.01% |
85,423
+1,885
| +2% | +$31.3K |
|
2502
iShares Silver Trust
SLV
$31.3B
| $1.58M | ﹤0.01% |
106,297
-20,559
| -16% | -$325K |
|
2503
Geospace Technologies
GEOS
$66.5M
| $1.58M | ﹤0.01% |
59,478
-96,344
| -62% | -$2.79M |
|
2504
TG Therapeutics
TGTX
$7.34B
| $1.58M | ﹤0.01% |
99,464
+5,489
| +6% | +$71.5K |
|
2505
iShares Core S&P Total US Stock Market ETF
ITOT
$98.5B
| $1.57M | ﹤0.01% |
33,426
+7,360
| +28% | +$337K |
|
2506
Restaurant Brands International
QSR
$26.7B
| $1.56M | ﹤0.01% |
+40,048
| New | +$1.54M |
|
2507
Celldex Therapeutics
CLDX
$3.35B
| $1.56M | ﹤0.01% |
5,690
+2,576
| +83% | +$640K |
|
2508
iShares US Healthcare Providers ETF
IHF
$1.26B
| $1.56M | ﹤0.01% |
65,775
+57,290
| +675% | +$1.29M |
|
2509
Wayfair
W
$13.9B
| $1.56M | ﹤0.01% |
+78,437
| New | +$1.88M |
|
|
ZEP
2510
DELISTED
ZEP INC COM STK (DE)
ZEP
| $1.56M | ﹤0.01% |
102,790
+2,216
| +2% | +$32.8K |
|
2511
Lloyds Banking Group
LYG
$90B
| $1.55M | ﹤0.01% |
334,650
+283,366
| +553% | +$1.37M |
|
|
HAPN
2512
Happen Inc
HAPN
$2.27B
| $1.53M | ﹤0.01% |
+12,102
| New | +$1.53M |
|
2513
CareTrust REIT
CTRE
$9.18B
| $1.53M | ﹤0.01% |
123,815
+36,616
| +42% | +$539K |
|
|
AGND
2514
DELISTED
WisdomTree Trust WisdomTree Negative Duration U.S. Aggregate Bond Fund
AGND
| $1.53M | ﹤0.01% |
33,889
+33,389
| +6,678% | +$1.53M |
|
|
WBK
2515
DELISTED
Westpac Banking Corporation
WBK
| $1.52M | ﹤0.01% |
56,106
+30,575
| +120% | +$864K |
|
|
MN
2516
DELISTED
MANNING & NAPIER, INC.
MN
| $1.51M | ﹤0.01% |
109,339
-52,683
| -33% | -$798K |
|
2517
NRC Health Common Stock
NRC
$471M
| $1.51M | ﹤0.01% |
107,940
| – | – |
|
2518
St. Joe Company
JOE
$3.89B
| $1.51M | ﹤0.01% |
82,050
-65,529
| -44% | -$1.24M |
|
|
NAB
2519
DELISTED
NATL AUSTRALIA BK LTD ADS5
NAB
| $1.51M | ﹤0.01% |
109,317
+25,913
| +31% | +$358K |
|
2520
Artivion
AORT
$1.39B
| $1.51M | ﹤0.01% |
133,126
+2,295
| +2% | +$23.8K |
|
|
LDR
2521
DELISTED
Landauer Inc
LDR
| $1.51M | ﹤0.01% |
44,106
+233
| +0.5% | +$7.94K |
|
|
NRCIB
2522
DELISTED
National Research Corp Class B
NRCIB
| $1.5M | ﹤0.01% |
41,929
| – | – |
|
|
BABS
2523
DELISTED
SPDR NUVEEN BARCLAYS BUILD AMERICA BOND ETF
BABS
| $1.5M | ﹤0.01% |
23,812
+23,088
| +3,189% | +$1.43M |
|
2524
Invesco Zacks Multi-Asset Income ETF
CVY
$125M
| $1.49M | ﹤0.01% |
66,600
-3,576
| -5% | -$83.9K |
|
|
MACK
2525
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $1.49M | ﹤0.01% |
16,722
+986
| +6% | +$71.8K |
|
Similar funds
Ameriprise's Q4 2014 Portfolio in Review
As of Q4 2014, Ameriprise held 6,323 positions worth $172B, up 3.2% from $166B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Ameriprise's Q4 2014 filing shows 103 new, 2,025 increased, 1,377 reduced and 2,563 closed positions. Its largest new stake was Travelport Worldwide Limited: 2,206,982 shares worth $39.7M. The largest sale was Gilead Sciences, an estimated $552M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q4 2014 buy was Travelport Worldwide Limited: 2,206,982 shares worth $39.7M.
- Ameriprise added most to Nike in Q4 2014, an estimated $499M increase.
- Ameriprise's biggest Q4 2014 reduction was Gilead Sciences, cutting an estimated $552M.
- Ameriprise fully exited CONCUR TECHNOLOGIES INC in Q4 2014, selling an estimated $50.5M.
- Ameriprise's ten largest holdings make up 12% of its $172B portfolio in Q4 2014.
- Ameriprise opened 103 new positions and closed 2,563 in Q4 2014.
- Ameriprise's portfolio value rose 3.2% quarter-over-quarter to $172B.
Based on Ameriprise's 13F filing for Q4 2014, filed 13 Feb 2015.